Online citations, reference lists, and bibliographies.

Biodegradable And Biocompatible Polymers‐Based Drug Delivery Systems For Cancer Therapy

Ibrahim M. El-Sherbiny, Nancy M. Elbaz, Amr H. Mohamed
Published 2015 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/0079-6700(92)90023-R
Poly (N-isopropylacrylamide) : experiment, theory and application
H. G. Schild (1992)
10.1038/nrc706
Multidrug resistance in cancer: role of ATP–dependent transporters
M. Gottesman (2002)
10.1016/j.tibtech.2008.06.007
Does a targeting ligand influence nanoparticle tumor localization or uptake?
K. Pirollo (2008)
10.1016/J.EURPOLYMJ.2014.04.020
pH/redox/photo responsive polymeric micelle via boronate ester and disulfide bonds with spiropyran-based photochromic polymer for cell imaging and anticancer drug delivery
S. Y. Lee (2014)
10.17795/JJNPP-3986
Comparison of Microencapsulation by Emulsion-Solvent Extraction/Evaporation Technique Using Derivatives Cellulose and Acrylate-Methacrylate Copolymer as Carriers
Mitra Jelvehgari (2012)
10.1073/pnas.1324135111
Remote loading of preencapsulated drugs into stealth liposomes
S. Sur (2014)
10.3390/10010146
Biodegradable Polymers for Microencapsulation of Drugs
J. Park (2005)
10.1016/J.PROGPOLYMSCI.2011.06.004
Biodegradable synthetic polymers: Preparation, functionalization and biomedical application
Huayu Tian (2012)
10.3390/POLYM3031377
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.
Hirenkumar K. Makadia (2011)
10.1126/science.1360704
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.
S. Cole (1992)
10.1016/J.JCONREL.2004.12.021
Role of polyanhydrides as localized drug carriers.
J. Jain (2005)
10.1016/J.JCONREL.2004.09.008
In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide).
Miechel L T Zweers (2004)
10.3390/polym5010161
Polyphosphazenes: Multifunctional, Biodegradable Vehicles for Drug and Gene Delivery
I. Teasdale (2013)
10.2147/IJN.S18905
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
R. Dinarvand (2011)
10.2147/IJN.S18535
Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations
P. Yousefpour (2011)
10.1016/j.biomaterials.2013.09.052
A pH and thermosensitive choline phosphate-based delivery platform targeted to the acidic tumor microenvironment.
X. Yu (2014)
10.1016/0168-3659(96)01369-7
Studies on diffusion in alginate gels. I. Effect of cross-linking with calcium or zinc ions on diffusion of acetaminophen
P. Aslani (1996)
10.1016/0378-5173(94)00324-X
Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery
L. Brannon-Peppas (1995)
10.1016/J.COLSURFB.2007.04.009
Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
Quan Gan (2007)
10.1016/0168-3659(95)00164-6
Biodegradable nanoparticles : From sustained release formulations to improved site specific drug delivery
J. Leroux (1996)
10.1163/156856292x00402
The development of polyanhydrides for drug delivery applications.
J. Tamada (1992)
10.1016/S0168-3659(01)00275-9
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
S. C. Kim (2001)
10.1016/j.jconrel.2014.06.062
Temperature-responsive polymeric micelles for optimizing drug targeting to solid tumors.
Jun Akimoto (2014)
10.1023/B:PHAM.0000003387.15428.42
PLGA/TPGS Nanoparticles for Controlled Release of Paclitaxel: Effects of the Emulsifier and Drug Loading Ratio
L. Mu (2004)
10.1016/j.colsurfb.2009.09.001
Biodegradable polymeric nanoparticles based drug delivery systems.
A. Kumari (2010)
10.1016/j.cub.2006.12.037
BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
M. Steegmaier (2007)
10.1016/J.BBRC.2007.06.102
Molecular cloning and functional analysis of a novel oncogene, cancer-upregulated gene 2 (CUG2).
S. Lee (2007)
10.1021/ma00079a001
Synthesis of poly(orgnaophosphazenes) with glycolic acid ester and lactic acid ester side groups: prototypes for new bioerodible polymers
H. Allcock (1994)
10.1016/0168-3659(93)90103-C
The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery
P. Scholes (1993)
10.1021/BC0340924
Synthesis of linear, beta-cyclodextrin-based polymers and their camptothecin conjugates.
J. Cheng (2003)
10.1016/S0168-3659(00)00280-7
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates.
H. Yoo (2000)
10.3390/jfb3030615
Biocompatibility of Chitosan Carriers with Application in Drug Delivery
S. Rodrigues (2012)
Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide.
J. Fang (2002)
10.1016/S0142-9612(03)00535-0
Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery.
A. Coombes (2004)
10.1016/j.biomaterials.2014.03.022
The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid-octadecylamine conjugate.
Zhennan She (2014)
10.1016/j.biomaterials.2008.04.023
On the mechanisms of biocompatibility.
D. Williams (2008)
10.1016/j.biomaterials.2013.01.084
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
R. Cheng (2013)
10.1038/nnano.2007.387
Nanocarriers as an emerging platform for cancer therapy.
D. Peer (2007)
10.1126/scitranslmed.3003651
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach (2012)
10.1016/0169-409X(95)00039-A
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
G. Storm (1995)
10.1016/j.jconrel.2012.12.013
Biocompatibility of engineered nanoparticles for drug delivery.
S. Naahidi (2013)
10.1021/bc00023a006
Temperature-responsive bioconjugates. 2. Molecular design for temperature-modulated bioseparations.
Y. Takei (1993)
10.1155/2013/374252
Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
S. Salmaso (2013)
10.1182/BLOOD.V96.10.3343
The molecular biology of chronic myeloid leukemia.
M. Deininger (2000)
10.1007/s10059-009-0083-2
Cancer-upregulated gene 2 (CUG2), a new component of centromere complex, is required for kinetochore function
Hyejin Kim (2009)
10.1126/science.2470152
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
D. Slamon (1989)
10.1007/s11426-014-5076-0
Biodegradable polymeric nanoparticles based on amphiphilic principle: construction and application in drug delivery
Shiyong Zhang (2014)
10.2147/IJN.S25182
Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
R. Ranganathan (2012)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1038/srep06314
Cancer Therapy Using Ultrahigh Hydrophobic Drug-Loaded Graphene Derivatives
Surajit Some (2014)
10.1016/S0142-9612(03)00348-X
Surface-engineered nanoparticles for multiple ligand coupling.
R. Gref (2003)
10.1016/j.jconrel.2014.05.048
Selective intracellular delivery of proteasome inhibitors through pH-sensitive polymeric micelles directed to efficient antitumor therapy.
Sabina Quader (2014)
10.1021/jf405675g
In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
G. Yang (2014)
10.1080/10611860400011935
Polymeric micelles for delivery of poorly soluble drugs: Preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids
Junping Wang (2005)
Acid pH in tumors and its potential for therapeutic exploitation.
I. Tannock (1989)
10.1016/j.biomaterials.2014.03.046
pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy.
Yi-Ting Chiang (2014)
10.1016/S1359-0286(02)00117-1
Biodegradable nanoparticles for drug delivery and targeting
M. Hans (2002)
10.1016/S0169-409X(02)00050-9
Polyanhydrides: an overview.
N. Kumar (2002)
10.1080/0265204031000093096
Preparation of microcapsules and control of their morphology
S. Kiyoyama (2003)
10.1016/J.DRUDIS.2006.07.005
Exploiting the enhanced permeability and retention effect for tumor targeting.
A. Iyer (2006)
10.1007/s00280-005-0091-7
Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing mice
Thomas Schluep (2005)
Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
R. Dagher (2002)
10.1016/J.JCONREL.2004.03.027
SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours.
K. Greish (2004)
10.1016/S0378-5173(02)00212-0
Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis.
M. Murillo (2002)
10.1038/bjc.1991.269
Drug-target interactions: only the first step in the commitment to a programmed cell death?
C. Dive (1991)
10.1074/JBC.M211758200
Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding*
M. F. Rosenberg (2003)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
10.1126/science.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1021/am501093a
Intracellular pH-sensitive metallo-supramolecular nanogels for anticancer drug delivery.
Xuemei Yao (2014)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1016/0142-9612(92)90028-M
Biodegradable polymers. II. Degradation characteristics of hydrolysis-sensitive poly[(organo)phosphazenes].
J. Crommen (1992)
10.1021/BC040297G
Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
K. Greish (2005)
10.1021/nl302638g
PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics.
J. Perry (2012)
10.1016/S0145-2126(01)00197-7
Bcr-Abl variants: biological and clinical aspects.
A. Advani (2002)
10.1002/wnan.1157
Recent advances in stealth coating of nanoparticle drug delivery systems.
Z. Amoozgar (2012)
10.1186/1477-3155-9-1
Synthesis of three-dimensional calcium carbonate nanofibrous structure from eggshell using femtosecond laser ablation
A. Tavangar (2011)
10.3390/ma6030738
“Smart” Materials Based on Cellulose: A Review of the Preparations, Properties, and Applications
Xiaoyun Qiu (2013)
10.1007/s10965-014-0506-4
Isothermal crystallization behavior of β-nucleated isotactic polypropylene with different melt structures
Jian Cheng Kang (2014)
10.1038/nm0195-27
Angiogenesis in cancer, vascular, rheumatoid and other disease
J. Folkman (1995)
Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents—Drug-Polymer Conjugates
P. Vasey (1999)
10.1186/1477-3155-9-55
Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines
A. Mahapatro (2011)
10.1021/MA011198Q
Thermoresponsive Polymeric Micelles with Controlled Instability Based on Hydrolytically Sensitive N-Isopropylacrylamide Copolymers
D. Neradovic (2001)
10.1016/j.jconrel.2014.09.009
Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
Shixian Lv (2014)
10.1016/J.IJPHARM.2004.12.010
Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer
D. Shenoy (2005)
10.1007/s10965-014-0567-4
Thermosensitive biotinylated hydroxypropyl cellulose-based polymer micelles as a nano-carrier for cancer-targeted drug delivery
M. Bagheri (2014)
10.1016/j.ejpb.2010.04.008
Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
Kenneth Ofokansi (2010)
10.1021/bm401471p
Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
Y. Yu (2014)
10.1016/S0167-4889(02)00256-2
Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis.
U. Nielsen (2002)
10.1039/C0SC00203H
Biocompatibility and drug delivery systems
D. Kohane (2010)
10.1016/0378-5173(95)00142-6
Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation
G. Puglisi (1995)
10.1016/S0009-2509(02)00578-X
Preparation of nanoparticles via spray route
K. Okuyama (2003)
10.1128/iai.48.3.747-753.1985
A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs.
R. Kamata (1985)
Tumor-targeting chemotherapy by a xanthine oxidase-polymer conjugate that generates oxygen-free radicals in tumor tissue.
T. Sawa (2000)
10.1016/S0168-3659(98)00116-3
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
T. Govender (1999)
10.1023/A:1016035229961
Morphological Characterization of Polyanhydride Biodegradable Implant Gliadel® During in Vitro and in Vivo Erosion Using Scanning Electron Microscopy
W. Dang (2004)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1016/S0021-9797(03)00519-8
Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol.
Ferry Iskandar (2003)
10.1016/0169-409X(95)00022-Y
Which polymers can make nanoparticulate drug carriers long-circulating?
V. Torchilin (1995)
10.1016/0169-409X(95)00025-3
Long circulating microparticulate drug carriers
S. Stolnik (1995)
10.1097/PPO.0b013e318213f3cf
Molecular Predictors of Response to Chemotherapy in Non-Small Cell Lung Cancer
J. Andrews (2011)
10.1016/S0168-3659(98)00030-3
Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
M. Lück (1998)
10.1016/S0939-6411(98)00017-4
Collagen--biomaterial for drug delivery.
W. Frieß (1998)
10.1002/1097-0142(19890201)63:3<604::AID-CNCR2820630334>3.0.CO;2-2
Side effects and emotional distress during cancer chemotherapy
R. Love (1989)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1016/S0378-5173(03)00128-5
Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety.
I. Kim (2003)
10.1006/BBRC.2001.5427
Heat shock proteins: endogenous modulators of apoptotic cell death.
C. Garrido (2001)
HER-2-targeted therapy: lessons learned and future directions.
R. Nahta (2003)
10.1016/S0168-3659(99)00242-4
Inner core segment design for drug delivery control of thermo-responsive polymeric micelles.
J. E. Chung (2000)
10.3109/02652048.2013.879932
Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells
Joy Wolfram (2014)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar